March 30-April 2, 2017
(Thursday-Sunday)
China National Convention Center(CNCC),Beijing,China
Program Search
Results:
Day/Time
Room
Section Type / Section Name
Name
Role
Presentation Title
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Patrick W. Serruys Moderator
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
William Wijns Moderator
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Yean-Leng Lim Discussant
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Davide Capodanno Discussant
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Mitchell W. Krucoff Discussant
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Tullio Palmerini Discussant
1:30 pm-3:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Wei Li Discussant
1:30 pm-1:42 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Bo Xu Lecturer A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): One-Year Clinical and Imaging Outcomes
1:48 pm-2:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Shaoliang Chen Lecturer Cut-off Value and Long-term Prediction of FFR Immediately after Implantation of a Drug-Eluting Stent for Clinical Events in Patients with Coronary Artery Disease: One-to-Three Year Results from DKCRUSH VII Registry Study
2:06 pm-2:18 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Xiaozeng Wang Lecturer A Prospective, Multicenter, Non-interventional Study Investigating the Incidence of Major Adverse Cardiovascular and Cerebrovascular Events in Chinese Patients Undergoing Percutaneous Coronary Interventions with Iodixanol
2:24 pm-2:36 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Zhe Zheng Lecturer Accuracy of Subjective SYNTAX Score Category Assessment and Influenced Factors in China
2:42 pm-2:54 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Late Breaking Clinical Trials and First Report Investigations
Quanmin Jing Lecturer A Multicenter Randomized Controlled Trial of Drug-Coated Balloon for the Treatment of Ostial Side Branch Stenosis in Bifurcation Lesion
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Dominick J. Angiolillo Moderator
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Thach Nguyen Moderator
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Takashi Akasaka Discussant
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Chung-Seung Chiang Discussant
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Fumiaki Ikeno Discussant
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Marie-Angèle Morel Discussant
3:30 pm-5:00 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Kai Wang Discussant
3:30 pm-3:42 pm,
Friday, March 31, 2017
Room 311A, Level 3 Late Breaking Trials
Featured Clinical Research
Bo Xu Lecturer Long-term Safety and Efficacy of the Resolute Stent: 5-Year Results from the RESOLUTE China Randomized Controlled Trial
Records:188 Pre[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Next